VYR-206

N/A

Report date: 2023/05/05 17:36:46
NME

Base Information

Drug NameVYR-206
Drug Alias NameVYR-206
ClassificationSmall molecules
Mechanisms of ActionCannabinoid CB1 receptor antagonistsNeurokinin 3 receptor antagonistsBradykinin B2 receptor antagonists
TargetsCannabinoid CB1 receptorNeurokinin 3 receptorBradykinin B2 receptor
Therapy Area/IndicationsNervous System DiseasesLymphoma, Mantle-CellPlasmablastic Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Yang-Ming University, Kaohsiung, Taiwan, Roc
China Registration ClassN/A

Develop Information

Active CompaniesNational Yang-Ming University, Kaohsiung, Taiwan, Roc
Inactive CompaniesN/A
Active IndicationsNervous System DiseasesLymphoma, Mantle-CellPlasmablastic Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A